Global Natamycin Market Analysis and Forecast 2024-2030

Global Natamycin Market Analysis and Forecast 2024-2030


Summary

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.

According to APO Research, The global Natamycin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Natamycin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Natamycin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Natamycin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Natamycin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Natamycin include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua and Zhengzhou New Frey, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Natamycin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Natamycin, also provides the sales of main regions and countries. Of the upcoming market potential for Natamycin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Natamycin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Natamycin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Natamycin sales, projected growth trends, production technology, application and end-user industry.

Natamycin segment by Company

Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome
Natamycin segment by Type

Glucose-based
Lactose-based
Sodium chloride-based
Natamycin segment by Application

Food
Medical
Others
Natamycin segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natamycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Natamycin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natamycin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Natamycin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Natamycin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Natamycin sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Natamycin Market by Type
1.2.1 Global Natamycin Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Glucose-based
1.2.3 Lactose-based
1.2.4 Sodium chloride-based
1.3 Natamycin Market by Application
1.3.1 Global Natamycin Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Food
1.3.3 Medical
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Natamycin Market Dynamics
2.1 Natamycin Industry Trends
2.2 Natamycin Industry Drivers
2.3 Natamycin Industry Opportunities and Challenges
2.4 Natamycin Industry Restraints
3 Global Market Growth Prospects
3.1 Global Natamycin Revenue Estimates and Forecasts (2019-2030)
3.2 Global Natamycin Revenue by Region
3.2.1 Global Natamycin Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Natamycin Revenue by Region (2019-2024)
3.2.3 Global Natamycin Revenue by Region (2025-2030)
3.2.4 Global Natamycin Revenue Market Share by Region (2019-2030)
3.3 Global Natamycin Sales Estimates and Forecasts 2019-2030
3.4 Global Natamycin Sales by Region
3.4.1 Global Natamycin Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Natamycin Sales by Region (2019-2024)
3.4.3 Global Natamycin Sales by Region (2025-2030)
3.4.4 Global Natamycin Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Natamycin Revenue by Manufacturers
4.1.1 Global Natamycin Revenue by Manufacturers (2019-2024)
4.1.2 Global Natamycin Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Natamycin Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Natamycin Sales by Manufacturers
4.2.1 Global Natamycin Sales by Manufacturers (2019-2024)
4.2.2 Global Natamycin Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Natamycin Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Natamycin Sales Price by Manufacturers (2019-2024)
4.4 Global Natamycin Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Natamycin Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Natamycin Manufacturers, Product Type & Application
4.7 Global Natamycin Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Natamycin Market CR5 and HHI
4.8.2 2023 Natamycin Tier 1, Tier 2, and Tier 3
5 Natamycin Market by Type
5.1 Global Natamycin Revenue by Type
5.1.1 Global Natamycin Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Natamycin Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Natamycin Revenue Market Share by Type (2019-2030)
5.2 Global Natamycin Sales by Type
5.2.1 Global Natamycin Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Natamycin Sales by Type (2019-2030) & (MT)
5.2.3 Global Natamycin Sales Market Share by Type (2019-2030)
5.3 Global Natamycin Price by Type
6 Natamycin Market by Application
6.1 Global Natamycin Revenue by Application
6.1.1 Global Natamycin Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Natamycin Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Natamycin Revenue Market Share by Application (2019-2030)
6.2 Global Natamycin Sales by Application
6.2.1 Global Natamycin Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Natamycin Sales by Application (2019-2030) & (MT)
6.2.3 Global Natamycin Sales Market Share by Application (2019-2030)
6.3 Global Natamycin Price by Application
7 Company Profiles
7.1 Danisco
7.1.1 Danisco Comapny Information
7.1.2 Danisco Business Overview
7.1.3 Danisco Natamycin Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Danisco Natamycin Product Portfolio
7.1.5 Danisco Recent Developments
7.2 DSM
7.2.1 DSM Comapny Information
7.2.2 DSM Business Overview
7.2.3 DSM Natamycin Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 DSM Natamycin Product Portfolio
7.2.5 DSM Recent Developments
7.3 VGP
7.3.1 VGP Comapny Information
7.3.2 VGP Business Overview
7.3.3 VGP Natamycin Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 VGP Natamycin Product Portfolio
7.3.5 VGP Recent Developments
7.4 Handary
7.4.1 Handary Comapny Information
7.4.2 Handary Business Overview
7.4.3 Handary Natamycin Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Handary Natamycin Product Portfolio
7.4.5 Handary Recent Developments
7.5 AMTECH BIOTECH
7.5.1 AMTECH BIOTECH Comapny Information
7.5.2 AMTECH BIOTECH Business Overview
7.5.3 AMTECH BIOTECH Natamycin Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 AMTECH BIOTECH Natamycin Product Portfolio
7.5.5 AMTECH BIOTECH Recent Developments
7.6 Silver-Elephant
7.6.1 Silver-Elephant Comapny Information
7.6.2 Silver-Elephant Business Overview
7.6.3 Silver-Elephant Natamycin Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Silver-Elephant Natamycin Product Portfolio
7.6.5 Silver-Elephant Recent Developments
7.7 Lanzhou Weiri
7.7.1 Lanzhou Weiri Comapny Information
7.7.2 Lanzhou Weiri Business Overview
7.7.3 Lanzhou Weiri Natamycin Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Lanzhou Weiri Natamycin Product Portfolio
7.7.5 Lanzhou Weiri Recent Developments
7.8 Langfang Meihua
7.8.1 Langfang Meihua Comapny Information
7.8.2 Langfang Meihua Business Overview
7.8.3 Langfang Meihua Natamycin Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Langfang Meihua Natamycin Product Portfolio
7.8.5 Langfang Meihua Recent Developments
7.9 Zhengzhou New Frey
7.9.1 Zhengzhou New Frey Comapny Information
7.9.2 Zhengzhou New Frey Business Overview
7.9.3 Zhengzhou New Frey Natamycin Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Zhengzhou New Frey Natamycin Product Portfolio
7.9.5 Zhengzhou New Frey Recent Developments
7.10 Chihon
7.10.1 Chihon Comapny Information
7.10.2 Chihon Business Overview
7.10.3 Chihon Natamycin Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Chihon Natamycin Product Portfolio
7.10.5 Chihon Recent Developments
7.11 Jiaozuo Joincare
7.11.1 Jiaozuo Joincare Comapny Information
7.11.2 Jiaozuo Joincare Business Overview
7.11.3 Jiaozuo Joincare Natamycin Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Jiaozuo Joincare Natamycin Product Portfolio
7.11.5 Jiaozuo Joincare Recent Developments
7.12 Beijing Oriental Rada
7.12.1 Beijing Oriental Rada Comapny Information
7.12.2 Beijing Oriental Rada Business Overview
7.12.3 Beijing Oriental Rada Natamycin Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Beijing Oriental Rada Natamycin Product Portfolio
7.12.5 Beijing Oriental Rada Recent Developments
7.13 Pucheng Lifecome
7.13.1 Pucheng Lifecome Comapny Information
7.13.2 Pucheng Lifecome Business Overview
7.13.3 Pucheng Lifecome Natamycin Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Pucheng Lifecome Natamycin Product Portfolio
7.13.5 Pucheng Lifecome Recent Developments
8 North America
8.1 North America Natamycin Market Size by Type
8.1.1 North America Natamycin Revenue by Type (2019-2030)
8.1.2 North America Natamycin Sales by Type (2019-2030)
8.1.3 North America Natamycin Price by Type (2019-2030)
8.2 North America Natamycin Market Size by Application
8.2.1 North America Natamycin Revenue by Application (2019-2030)
8.2.2 North America Natamycin Sales by Application (2019-2030)
8.2.3 North America Natamycin Price by Application (2019-2030)
8.3 North America Natamycin Market Size by Country
8.3.1 North America Natamycin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Natamycin Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Natamycin Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Natamycin Market Size by Type
9.1.1 Europe Natamycin Revenue by Type (2019-2030)
9.1.2 Europe Natamycin Sales by Type (2019-2030)
9.1.3 Europe Natamycin Price by Type (2019-2030)
9.2 Europe Natamycin Market Size by Application
9.2.1 Europe Natamycin Revenue by Application (2019-2030)
9.2.2 Europe Natamycin Sales by Application (2019-2030)
9.2.3 Europe Natamycin Price by Application (2019-2030)
9.3 Europe Natamycin Market Size by Country
9.3.1 Europe Natamycin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Natamycin Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Natamycin Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Natamycin Market Size by Type
10.1.1 China Natamycin Revenue by Type (2019-2030)
10.1.2 China Natamycin Sales by Type (2019-2030)
10.1.3 China Natamycin Price by Type (2019-2030)
10.2 China Natamycin Market Size by Application
10.2.1 China Natamycin Revenue by Application (2019-2030)
10.2.2 China Natamycin Sales by Application (2019-2030)
10.2.3 China Natamycin Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Natamycin Market Size by Type
11.1.1 Asia Natamycin Revenue by Type (2019-2030)
11.1.2 Asia Natamycin Sales by Type (2019-2030)
11.1.3 Asia Natamycin Price by Type (2019-2030)
11.2 Asia Natamycin Market Size by Application
11.2.1 Asia Natamycin Revenue by Application (2019-2030)
11.2.2 Asia Natamycin Sales by Application (2019-2030)
11.2.3 Asia Natamycin Price by Application (2019-2030)
11.3 Asia Natamycin Market Size by Country
11.3.1 Asia Natamycin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Natamycin Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Natamycin Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Natamycin Market Size by Type
12.1.1 MEALA Natamycin Revenue by Type (2019-2030)
12.1.2 MEALA Natamycin Sales by Type (2019-2030)
12.1.3 MEALA Natamycin Price by Type (2019-2030)
12.2 MEALA Natamycin Market Size by Application
12.2.1 MEALA Natamycin Revenue by Application (2019-2030)
12.2.2 MEALA Natamycin Sales by Application (2019-2030)
12.2.3 MEALA Natamycin Price by Application (2019-2030)
12.3 MEALA Natamycin Market Size by Country
12.3.1 MEALA Natamycin Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Natamycin Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Natamycin Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Natamycin Value Chain Analysis
13.1.1 Natamycin Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Natamycin Production Mode & Process
13.2 Natamycin Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Natamycin Distributors
13.2.3 Natamycin Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings